Citation sources

Updated weekly. Details via Crossref
Crossref Scopus Google Scholar
14 11 Search
2024
Uncommon Haematological Transformation: Chronic Myeloid Leukaemia Transitioning Into Plasma Cell Leukaemia in a Single Patient
Cureus
2024
Transcriptomic analysis delineates potential regulatory network as therapeutic alternatives in chronic myeloid leukemia
Egyptian Journal of Medical Human Genetics
2023
Abl kinases can function as suppressors of tumor progression and metastasis
Frontiers in Oncology
2023
Secondary Ovarian Malignancy in an Imatinib treated Chronic Myeloid Leukemia Patient Diagnosed on Fluid Cytology
Clinical Cancer Investigation Journal
2022
Cross-Domain Text Mining to Predict Adverse Events from Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia
Cancers
2022
Development of plasma cell dyscrasias in a patient with chronic myeloid leukemia: A case report
World Journal of Clinical Cases
2022
A case report of coexistent carcinoma breast with chronic myeloid leukemia
Indian Journal of Pathology and Oncology
2021
Significant current epidemiological trend: Haematological malignancies as subsequent primary tumours in cancer patients
Cancer Epidemiology
2021
Deciphering the Risk of Developing Second Primary Thyroid Cancer Following a Primary Malignancy—Who Is at the Greatest Risk?
Cancers
2021
Hodgkin Lymphoma as a Secondary Neoplasm During Therapy for Chronic Myeloid Leukaemia: Case Report and Review of the Literature
OncoTargets and Therapy
2020
TARGET: a survey of real‐world management of chronic myeloid leukaemia across 33 countries
British Journal of Haematology
2020
Occurrence of lymphoplasmacytic lymphoma in a chronic myeloid leukemia patient following long-term treatment with tyrosine kinase inhibitors
Medicine
2020
Clinical features and prognosis of duplex primary malignant neoplasms involving chronic myeloid leukemia
Medicine
2020
Cardiovascular mortality among chronic myeloid leukemia patients in the pre-tyrosine kinase inhibitor (TKI) and TKI eras: a surveillance, epidemiology and end results (SEER) analysis
Leukemia & Lymphoma
2019
Incidence of second malignancies in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitors
International Journal of Hematology
Additional cited-by details will be shown when available from Crossref